Archean Chemical Industries Limited carries a market capitalization of 65.42B, placing it among publicly traded companies globally. Its enterprise value stands at 75.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 65.42B |
| Enterprise Value | 75.82B |
Archean Chemical Industries Limited currently has 123.46M shares outstanding.
| Shares Outstanding | 123.46M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Archean Chemical Industries Limited trades at a trailing price-to-earnings ratio of 67.51. The price-to-sales ratio is 6.64, and the price-to-book ratio stands at 7.35.
| PE Ratio | 67.51 |
| PS Ratio | 6.64 |
| PB Ratio | 7.35 |
| P/TBV Ratio | 3.94 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Archean Chemical Industries Limited trades at an EV/EBITDA multiple of 51.97 and an EV/FCF ratio of 410.97. The EV/Sales ratio of 7.01 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 51.97 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.01 |
| EV / EBITDA | 51.97 |
| EV / EBIT | 51.97 |
| EV / FCF | 410.97 |
Archean Chemical Industries Limited maintains a current ratio of 1.21, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 24.13, indicating elevated leverage, while an interest coverage ratio of 5.67 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.21 |
| Quick Ratio | 0.14 |
| Debt / Equity | 24.13 |
| Debt / EBITDA | 3.20 |
| Interest Coverage | 5.67 |
Archean Chemical Industries Limited posts a return on equity of 11.29 and a return on invested capital of 4.70.
| Return on Equity (ROE) | 11.29 |
| Return on Assets (ROA) | 4.21 |
| Return on Invested Capital (ROIC) | 4.70 |
| Return on Capital Employed (ROCE) | 9.73 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.34 |
Over the trailing twelve months, Archean Chemical Industries Limited has paid 416.88M in income taxes, reflecting an effective tax rate of 28.34.
| Income Tax | 416.88M |
| Effective Tax Rate | 28.34 |
Archean Chemical Industries Limited's stock has declined approximately -16.492% over the past 52 weeks. The 50-day moving average sits at 551.78, while the 200-day moving average is 572.81.
| Beta (5Y) | N/A |
| 52-Week Price Change | -16.492% |
| 50-Day Moving Average | 551.78 |
| 200-Day Moving Average | 572.81 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Archean Chemical Industries Limited generated 10.81B in revenue and converted that into 1.06B in net income, yielding earnings per share of 8.61. EBITDA reached 1.46B, while operating income came in at 1.46B.
| Revenue | 10.81B |
| Gross Profit | 10.17B |
| Operating Income | 1.46B |
| Pretax Income | 1.47B |
| Net Income | 1.06B |
| EBITDA | 1.46B |
| EBIT | 1.46B |
| Earnings Per Share (EPS) | 8.61 |
Archean Chemical Industries Limited holds 611.21M in cash and equivalents against 4.66B in total debt, resulting in a net debt position of 3.64B. Total book value stands at 9.77B, with working capital of 930.31M providing operational flexibility.
| Cash & Cash Equivalents | 611.21M |
| Total Debt | 4.66B |
| Net Debt | 3.64B |
| Equity (Book Value) | 9.77B |
| Book Value Per Share | 79.94 |
| Working Capital | 930.31M |
Archean Chemical Industries Limited operates with a gross margin of 94.06, reflecting its pricing power and cost economics. The operating margin of 13.50 and net profit margin of 9.84 provide insight into operational efficiency.
| Gross Margin | 94.06 |
| Operating Margin | 13.50 |
| Pretax Margin | 13.61 |
| Profit Margin | 9.84 |
| EBITDA Margin | 13.50 |
Archean Chemical Industries Limited posts an Altman Z-Score of 7.06, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.06 |